Learn more about our superior nicotine gum and how it is adapted to fit a market with huge potential.
Realize the benefits of our technology for development of active gums.
Learn more about how to become a partner and what´s in our pipeline.
Enorama Pharma has received approval from the Swedish MPA for each of the Company's four nicotine products.
Enorama Pharma believes that there will be a great need for serious cannabis products in the future.
This decision does not affect Enorama Pharma's ongoing development work in India.
Enorama Pharma travels to Athens to meet several potential customers.
In February 2019, Enorama Pharma entered into an agreement with the company MediiGum LLC.
The Company establishes a development laboratory at Malmö University's Open Lab, Sweden.